• China: Draft Guidelines on Export Drug Inspections & Certificates

    Ensuring Compliance and Quality Management for Drug Exports

    Published: 21-Nov-2025

    Consult NowKnow More
    NMPA | Pharmaceuticals | Regulatory Affairs

  • China: Technical Guidelines for Common Problems in Drug Development and Clinical Trial Application (Draft for Comments)

    Enhancing Regulatory Communication and Drug Development Quality

    Published: 18-Nov-2025

    Consult NowKnow More
    NMPA | Pharmaceuticals | Regulatory Affairs

  • China: Draft Guidelines for Electronic Data in Clinical Trials (For Comments)

    Strengthening data integrity and system validation.

    Published: 24-Nov-2025

    Consult NowKnow More
    NMPA | Pharmaceuticals | Regulatory Affairs

  • Saudi Arabia: SFDA Links National Pharmacovigilance Database with WHO Global Platform

    Enhancing Drug Safety Through Global Data Integration

    Published: 24-Nov-2025

    Consult NowKnow More
    SFDA | Pharmaceuticals | Regulatory Affairs

  • Saudi Arabia: Pharmaceutical Pricing Mechanisms & Rules (Draft)

    Strengthening Price Implementation & Pricing Framework

    Published: 20-Nov-2025
    Consultation Period: 20-Nov-2025 to 20-Dec-2025
     

    Consult NowKnow More
    SFDA | Pharmaceuticals | Regulatory Affairs